glycyrrhizic acid has been researched along with cardiovascular agents in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ho, JW; Jie, M | 1 |
| Chen, J; Chen, S; Jiang, H; Xu, C; Xu, L; Yang, J; Zhang, J | 1 |
1 review(s) available for glycyrrhizic acid and cardiovascular agents
| Article | Year |
|---|---|
Pharmacological activity of cardiovascular agents from herbal medicine.
Topics: Alkaloids; Astragalus propinquus; Biphenyl Compounds; Cardiovascular Agents; Drugs, Chinese Herbal; Flavonoids; Glycyrrhizic Acid; Herbal Medicine; Humans; Lignans; Phenanthrenes; Pyrazines | 2007 |
1 other study(ies) available for glycyrrhizic acid and cardiovascular agents
| Article | Year |
|---|---|
Inhibition of neointimal hyperplasia in the rat carotid artery injury model by a HMGB1 inhibitor.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Antioxidants; Cardiovascular Agents; Carotid Arteries; Carotid Artery Injuries; Cell Differentiation; Cell Movement; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Glycyrrhizic Acid; HMGB1 Protein; Hyperplasia; Inflammation Mediators; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; NF-kappa B; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phenotype; Rats; Rats, Sprague-Dawley; Receptors, Notch; Signal Transduction; Time Factors | 2012 |